Icon
+91 94997 68112
Login Register

Stribild - (150mg; 150mg; 200mg; 300mg; Tablet, Oral)

Cobicistat;Elvitegravir;Emtricitabine;Tenofovir Disoproxil Fumarate Gilead
150mg; 150mg; 200mg; 300mg; Tablet, Oral
Less Than $1000 mn
Less Than 5
Less Than 5
Less Than 5
 None
None None
Used as a complete regimen for the treatment of HIV-1 infection
Yes
Stribild Patent 1 Patent 2 Patent 3 Patent 4 Patent 5 Patent 6 Patent 7 Patent 8 Patent 9 Patent 10 Patent 11 Patent 12 Patent 13
***** ******* ******* ******* ******* ******* ******* ******* ******* ******* ******* ******* ******* *******
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
***** *** \ ********* **** **, **** ******* **** ***** **** **** (******** ******)
  1. *** **, **** : ** ********* ******* ***** ******* *** ******, ****** ****** ********** ******** ***, *** ********, *** **** *********** (“***”) **. ****** *** ********
  2. *** **, **** : ***** ******** ** *** ****** ***** **'* **** ** ************* **** ****** ******* (***** **, ****)
  3. *** **, **** : ****** *** ** ***** * **** ******* ***** ** ****** ******* (***** **, ****)
  4. *** *, **** : ********** *** ********* **** *****

Download ParaIV Report

Download ParaIV Detailed Report

To get detailed report Contact Us

ParaIV Advanced Search






Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.